ANIP ANI PHARMACEUTICALS INC Investor Conferences 8-K Filing 2025 - Investor Meetings On May 20, 2025, ANI Pharmaceuticals, Inc. announced that CEO Nikhil Lalwani will present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference in New York, with an investor presentation attached as Exhibit 99.1.Get access to all SEC 8-K filings of the ANI PHARMACEUTICALS INC